Tuberculosis Cell Mediated Immunity Antigen Response (QuantiFERON®-TB Gold ) Test
QuantiFERON®-TB Gold is used to diagnose active Mycobacterium tuberculosis (TB) infection in patients suspected of having TB infection and in patients exposed to TB infection. This test belongs to whole blood test Interferon-Gamma Release Assays (IGRAs) with principles based on quantifying the interferon released from lymphocytes when incubated with purified protein derivative.
Previously the tuberculin skin test (TST) was the method of choice to diagnose latent tuberculosis infection (LTBI); however, there are many noted advantages in the use of quantiferon such as: Single patient visit, assesses responses to multiple antigens simultaneously, does not boost anamnestic immune responses and less subjective than the TST.
Results from the LTBI and TST are not interchangeable and should not be read as such. Another method used to diagnose tuberculin infection is with the use of the sputum smear and culture. Both have limitations in regards to subjectivity and the length of culture time involved, whereas quantiferon removes these limitations. Due to the methodology of this test, patients with lymphocytopenia due to a secondary or underlying disease should be interpreted differently than a patient with a normal or elevated lymphocyte count. A limitation of quantiferon is that it does not distinguish between previous and currently active infection, only that there was an infection at one point. A positive result supports the diagnosis of tuberculosis disease; however, infections by other mycobacteria (e.g., M. kansasii) could also lead to positive results.
The QuantiFERON®-TB Gold IT system uses specialized blood collection tubes, which are used to collect whole blood. Incubation of the blood occurs in the tubes for 16 to 24 hours, after which, plasma is harvested and tested by ELISA for the presence of IFN-gamma produced in response to the peptide antigens.
- As an aid in the diagnosis of active Mycobacterium tuberculosis infection
- As an aid in the diagnosing latent Mycobacterium tuberculosis infections
- Screening for Mycobacterium tuberculosis exposure and infection
Increased in:
- Mycobacterium tuberculosis active infections
- Mycobacterium tuberculosis latent infection
- Some non-tuberculous mycobacterial infections such as M. kansasii, M. szulgai and M. marinum
Negative (Non-reactive)
Quantiferon TB Gold (QFT) kit ( 3 Tubes)
(1) QFT-NIL Control Tube WB, (2) QFT-TB Antigen Tube WB & (3) QFT-Mitogen Control WB
This test is time sensitive and samples must be received in the laboratory within 14 hours of collection for incubation.
- Collect 1 mL of blood by venipuncture directly into each of the three (3) unique QuantiFERON(R)-TB Gold IT collection tubes (Nil, TB Antigen, Mitogen). Under or overfilling of the tubes may lead to erroneous results.
- Immediately after filling the tubes, shake them ten times just firmly enough to ensure the entire surface of the tube is coated with blood, to solubilize antigens on tube walls.
- Incubate the three (3) tubes upright at 36-38 degrees C for 16 to 24 hours.
- Centrifuge each of the three (3) incubated collection tubes for 15 minutes at 2000 to 3000 RCF (g). Label with patient name, identification number and date of collection
- Sample will be Stable for 28 days Refrigerated.
- Lancet. 2000;356:1099-104. [PMID: 11009160]
- Infect Immun. 2000;68:3314-21 [PMID: 10816479]
- Eur Respir J.2007;30: 945-950. [PMID: 17652312]
- BMC Pulm Med. 2009 May 16;9:21. [PMID: 19445695]
- Eur Respir J. 2011 Jan;37(1):100-11. [PMID: 20847080]
- http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5202a2.htm